419 related articles for article (PubMed ID: 15471225)
1. In vitro selection of HIV and CMV specific T-lymphocytes.
Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
[TBL] [Abstract][Full Text] [Related]
2. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
[TBL] [Abstract][Full Text] [Related]
3. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
6. Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity, by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire.
Li Pira G; Bottone L; Ivaldi F; Tagliamacco A; Fiordoro S; Ricciardi A; Barbano G; Manca F
J Infect Dis; 2005 Jan; 191(2):215-26. PubMed ID: 15609231
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
[TBL] [Abstract][Full Text] [Related]
8. Selective binding of CD4 and CD8 T-cells to antigen presenting cells for enrichment of CMV and HIV specific T-lymphocytes.
Li Pira G; Ivaldi F; Manca F
J Immunol Methods; 2012 Feb; 376(1-2):125-31. PubMed ID: 22251662
[TBL] [Abstract][Full Text] [Related]
9. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection.
Yu J; Chen H; Horton H; Bansal A; McElrath JM; Reichman R; Goepfert P; Jin X
J Med Virol; 2006 Sep; 78(9):1147-57. PubMed ID: 16847956
[TBL] [Abstract][Full Text] [Related]
11. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
[TBL] [Abstract][Full Text] [Related]
12. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
[TBL] [Abstract][Full Text] [Related]
13. Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution.
Li Pira G; Bottone L; Ivaldi F; Pelizzoli R; Del Galdo F; Lozzi L; Bracci L; Loregian A; Palù G; De Palma R; Einsele H; Manca F
Int Immunol; 2004 May; 16(5):635-42. PubMed ID: 15096491
[TBL] [Abstract][Full Text] [Related]
14. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
Nastke MD; Herrgen L; Walter S; Wernet D; Rammensee HG; Stevanović S
Cell Mol Life Sci; 2005 Jan; 62(1):77-86. PubMed ID: 15619009
[TBL] [Abstract][Full Text] [Related]
15. Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library.
Dander E; Li Pira G; Biagi E; Perseghin P; Renoldi G; Gaipa G; Introna M; Marin V; Manca F; Biondi A; D'Amico G
Exp Hematol; 2008 Apr; 36(4):473-85. PubMed ID: 18261836
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus (CMV)-specific cellular immune responses.
Harari A; Zimmerli SC; Pantaleo G
Hum Immunol; 2004 May; 65(5):500-6. PubMed ID: 15172450
[TBL] [Abstract][Full Text] [Related]
17. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.
Stone SF; Price P; French MA
J Antimicrob Chemother; 2006 Apr; 57(4):585-8. PubMed ID: 16504998
[TBL] [Abstract][Full Text] [Related]
19. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
20. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
